http://pharmtech.findpharma.com/pharmtech/Manufacturing/Article/list/40939 Equipment and processing in pharma, biopharma, specialty & generic drug manufacturing. Aseptic processing, cytotoxic manufacturing, small & large molecules. 2009-11-22T05:52:56Z http://pharmtech.findpharma.com/pharmtech/Manufacturing/Right-first-time-drug-manufacture/ArticleStandard/Article/detail/642528?contextCategoryId=40939&ref=25 Engineers at a UK university claim to have developed technology that can be used in existing chemical reactors to ensure right first time drug crystal formation, which is crucial to their efficacy and the efficiency of pharmaceutical manufacturers' operations. 2009-11-20T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642528null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Pfizer-Announces-RampD-Facility-Consolidation/ArticleStandard/Article/detail/642582?contextCategoryId=40939&ref=25 Following the its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York) Pfizer detailed plans for its global research and development (R&D) network, which includes consolidation of its R&D facilities. 2009-11-19T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642582null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-16-2009-GSK-and-Nabi-Form-Nicotine-Vac/ArticleStandard/Article/detail/642581?contextCategoryId=40939&ref=25 Company and People Notes: Genzyme provides updates on enzyme replacement products and FDA complete response letter; Watson appoints VP of global operations; more... 2009-11-19T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642581null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/GSK-Donates-Influenza-A-H1N1-Vaccine-to-WHO/ArticleStandard/Article/detail/642555?contextCategoryId=40939&ref=25 Last week, GlaxoSmithKline (GSK, London) agreed to donate 50 million doses of its adjuvanted pandemic influenza A (H1N1) vaccine to the World Health Organization (WHO). 2009-11-19T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642555null HTML http://pharmtech.findpharma.com/pharmtech/Editor%27s+Picks/November-2009-Editors-Picks-Products-from-Enercon-/ArticleStandard/Article/detail/641618?contextCategoryId=40939&ref=25 PharmTech's monthly newsletter, Equipment & Processing Report, reviews the Editor's Picks for the November 2009 edition from Enercon and Schreiner. 2009-11-18T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/641618null HTML http://pharmtech.findpharma.com/pharmtech/In+the+Mixer/Pigging-Can-Improve-Efficiency-and-Sustainability/ArticleStandard/Article/detail/641599?contextCategoryId=40939&ref=25 Pigging is a sustainable strategy that can aid in cleaning and product recovery and improve a manufacturing line's efficiency and throughput. 2009-11-18T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/641599null HTML http://pharmtech.findpharma.com/pharmtech/Online+Only/Are-Microreactors-Practical-for-Large-Scale-Produc/ArticleStandard/Article/detail/641595?contextCategoryId=40939&ref=25 Recent advances in microreactor technology are improving the application and scale at which the technology can be applied. 2009-11-18T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/641595null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Choosing-the-best-construction-material-for-powder/ArticleStandard/Article/detail/641749?contextCategoryId=40939&ref=25 Selecting the best material of construction is a crucial part of the plant design process, the aim being to balance performance and cost to best advantage. For powder processors, choosing a material that eases flow can pay dividends throughout the lifetime of the plant, but there is limited data on which to base this decision. A recent study by Freeman Technology highlights the role of the FT4 universal powder tester for such studies and provides some valuable comparative data for a wide range of commercially available materials and finishes. 2009-11-13T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/641749null REMOTE http://pharmtech.findpharma.com/pharmtech/Whitepapers/Protect-Your-Scientific-Intellectual-Property-Proo/ArticleStandard/Article/detail/641752?contextCategoryId=40939&ref=25 As a pharmaceutical or biotechnology organization, your formulas, treatments and clinical findings are the "lifeblood" of your business. But if you aren't protecting the integrity of your scientific data in your lab informatics systems, you risk losing ownership, revenue and consequently your business if you can't prove time-of-creation and authenticity. Learn how you can implement simple, cost-effective, and automated controls to protect your scientific intellectual property. 2009-11-13T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/641752null REMOTE http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/AAPS-Announces-Annual-Awards-Names-2009-Fellows/ArticleStandard/Article/detail/640909?contextCategoryId=40939&ref=25 The American Association of Pharmaceutical Scientists (AAPS) recognized researchers at the organization's 2009 Annual Meeting and Exposition in Los Angeles this week. 2009-11-12T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640909null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Novartis-Updates-Vaccine-Progress-in-Germany-Acqui/ArticleStandard/Article/detail/640743?contextCategoryId=40939&ref=25 Novartis reported that German regulatory authorities approved its adjuvanted cell culture-based Influenza A (H1N1) 2009 monovalent vaccine, Celtura. The company also said it will acquire a stake in Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical. 2009-11-12T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640743null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/UK-Backs-Continuous-Processing/ArticleStandard/Article/detail/640757?contextCategoryId=40939&ref=25 A consortium led by GlaxoSmithKline (UK) intends to deliver a "step change improvement" in pharmaceutical tablet manufacturing in the UK by "substantially" increasing the country's manufacturing efficiency. 2009-11-12T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640757null HTML http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Nov-9-2009-Merck-and-Schering-Plough-Begin/ArticleStandard/Article/detail/640959?contextCategoryId=40939&ref=25 Company and People Notes: 3M forms agreement with VaxInnate; TRIN Pharma appoints CEO; More... 2009-11-12T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640959null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/PhRMA-Reacts-to-House-Healthcare-Reform-Bill/ArticleStandard/Article/detail/640751?contextCategoryId=40939&ref=25 On Sunday, Nov. 8, 2009, the Pharmaceutical Research and Manufacturers of America (PhRMA) expressed its disappointment with the US House of Representatives's healthcare-reform bill. 2009-11-12T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640751null HTML http://pharmtech.findpharma.com/pharmtech/News/New-speciality-pharma-company-formed-in-Sweden/ArticleStandard/Article/detail/639927?contextCategoryId=40939&ref=25 A new pharmaceutical company with a focus on rare diseases has been formed in Sweden following the merger of the Swedish companies Biovitrum and Swedish Orphan. 2009-11-06T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639927null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Europe-May-See-10-New-Orphan-Products-a-Year/ArticleStandard/Article/detail/638999?contextCategoryId=40939&ref=25 The European Organization for Rare Diseases (EURORDIS) predicts that 100 new designated orphan products will receive marketing authorization between 2009 and 2019, which equates to approximately 10 new products every year. 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638999null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/SOCMA-Hails-FDA-Action-on-Citizen-Petition-Regardi/ArticleStandard/Article/detail/639211?contextCategoryId=40939&ref=25 The Society of Chemical Manufacturers and Affiliates (SOCMA) reported last week that the US Food and Drug Administration responded to the association's citizen petition relating to the inspection process of foreign drug-manufacturing facilities. 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639211null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Novartis-To-Invest-1-Billion-in-China-RampD-Instit/ArticleStandard/Article/detail/638992?contextCategoryId=40939&ref=25 Novartis (Basel, Switzerland) plans to invest $1 billion over the next five years to increase research and development activities in China, including a significant expansion of The Novartis Institute of BioMedical Research (CNIBR) in Shanghai. 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638992null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?contextCategoryId=40939&ref=25 Company and People Notes: sanofi aventis forms pact with Micromet; Laureate Pharma adds members to its business team. 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639212null HTML http://pharmtech.findpharma.com/pharmtech/Formulation/USP-Revises-Excipient-Standards-to-Limit-Contamina/ArticleStandard/Article/detail/639036?contextCategoryId=40939&ref=25 In response to a request from the US Food and Drug Administration, the US Pharmacopeial Convention (USP) revised its standards for propylene glycol and sorbitol solution 2009-11-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639036null HTML http://pharmtech.findpharma.com/pharmtech/Article/Moisture-Activated-Dry-GranulationmdashPart-I-A-Gu/ArticleStandard/Article/detail/639196?contextCategoryId=40939&ref=25 The authors explain a process for moisture-activated dry granulation in detail and provide guidance for the selection of excipients and equipment. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639196/pt1109-fig-1-P64B_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639196null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Sharing-Supply-Chain-Security/ArticleStandard/Article/detail/639209?contextCategoryId=40939&ref=25 A panel of industry and regulatory experts, including FDA, discuss efforts to secure the global pharmaceutical supply chain. This article contains bonus online-exclusive material. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639209/pt1109_coverstory_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639209/Bonus_main.gif http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639209null XML http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?contextCategoryId=40939&ref=25 FDA's Edwin Rivera-Martinez on dodging supply-chain challenges. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639195null XML http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Facing-Reality/ArticleStandard/Article/detail/639202?contextCategoryId=40939&ref=25 Contract organizations waiting for the pipeline to come roaring back are kidding themselves. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639202null XML http://pharmtech.findpharma.com/pharmtech/Article/Position-Paper-Are-We-Abandoning-IQ-and-OQ/ArticleStandard/Article/detail/639199?contextCategoryId=40939&ref=25 The author explores differences between two qualification documents, the draft guidance from FDA "Process Validation: General Principles and Practice" and the ASTM E2500-7 standard "Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment." 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639199/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639199null XML http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/639200?contextCategoryId=40939&ref=25 Editors' Picks of Pharmaceutical Science & Technology Innovations 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639200null XML http://pharmtech.findpharma.com/pharmtech/Article/Report-from-the-Philippines/ArticleStandard/Article/detail/639208?contextCategoryId=40939&ref=25 New pricing controls and healthcare reforms may be pushing the pharmaceutical market out of this southeast Asian country. This article contains bonus online-exclusive material. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639208/pt-1109-Philippines-p18_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639208/Bonus_main.gif http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639208null XML http://pharmtech.findpharma.com/pharmtech/Article/Safety-versus-Speed-in-Drug-Development/ArticleStandard/Article/detail/639197?contextCategoryId=40939&ref=25 The heightened focus on risk raises concerns about delays in approving new drugs. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639197null XML http://pharmtech.findpharma.com/pharmtech/Article/Changes-for-Better-or-Worse/ArticleStandard/Article/detail/639201?contextCategoryId=40939&ref=25 New tests solve one issue, but cheaper plastic and new stoppers cause problems. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639201null XML http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?contextCategoryId=40939&ref=25 While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the game too. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639194null XML http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Advancing-Chiral-Chemistry-in-API-Synthesis/ArticleStandard/Article/detail/639207?contextCategoryId=40939&ref=25 Functionalized supramolecular catalysts and an enantioselective route to unnatural amino acids are some recent developments. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639207/pt-1109-p44-Ingredients_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639207null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Whatever-Happened-to-Classical-Chemistry/ArticleStandard/Article/detail/639203?contextCategoryId=40939&ref=25 A recent book reminds readers that small-molecule chemistry has enabled advances in biotechnology. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639203/pt-1109-Vetterlein-book-B_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639203/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639203null XML http://pharmtech.findpharma.com/pharmtech/Article/A-Robust-Automated-Karl-Fischer-Titration-System/ArticleStandard/Article/detail/639198?contextCategoryId=40939&ref=25 The authors developed a robust, automated system to conduct Karl Fischer moisture assays for lyophilized products. 2009-11-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639198/pt-1109-fig-2-p58B_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639198null XML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Risk-Management-for-Aseptic-Processing/ArticleStandard/Article/detail/638758?contextCategoryId=40939&ref=25 The author discusses the risks involved with aseptic processing, methods and tools used to identify and control risk, and regulatory guidelines relevant to the risk-management process. 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638758/pt1109-sup-needles-CV-B_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638758null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Targeting-Therapeutics-for-the-Middle-and-Inner-Ea/ArticleStandard/Article/detail/638761?contextCategoryId=40939&ref=25 A Conversation with Otonomy 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638761/pt1109-sup-needles-CV-B_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638761null XML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Demographic-time-bomb/ArticleStandard/Article/detail/637635?contextCategoryId=40939&ref=25 Population ageing is an issue often discussed in the media, but its impact on all facets of life has been poorly characterized. 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637635null XML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Technology-Forecast-for-Injectables/ArticleStandard/Article/detail/638759?contextCategoryId=40939&ref=25 A Conversation with Greystone Associates' George Perros. This article contains bonus online-exclusive material. 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638759/pt1109-sup-needles-CV-B_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638759/Bonus_main.gif http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638759null XML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/From-Needle-to-Pill-Reformulating-Injectable-Drugs/ArticleStandard/Article/detail/638762?contextCategoryId=40939&ref=25 The author describes how Merrion Pharmaceuticals reformulates parenteral drugs into tablets and capsules that are easier for patients to take and provide better bioavailability. 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638762/pt1109-sup-needles-CV-B_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638762null XML http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/Preventing-counterfeits-from-entering-the-supply-c/ArticleStandard/Article/detail/635815?contextCategoryId=40939&ref=25 With counterfeit drugs on the rise, the Chairman and CEO of Ahura Scientific discusses the issue and explains how a handheld device is helping companies to tackle the problem. 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635815/doug_thumbnail_thumbnail.gif http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635815null HTML http://pharmtech.findpharma.com/pharmtech/Formulation/Current-Perspectives-on-Aseptic-Formulations/ArticleStandard/Article/detail/638763?contextCategoryId=40939&ref=25 The author details the factors in formulation design, requirements in facilites and equipment, and validation criteria for aseptic formualtions. 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638763/pt1109-sup-needles-CV-B_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638763null XML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Sustainability-in-the-packaging-supply-chain/ArticleStandard/Article/detail/631118?contextCategoryId=40939&ref=25 Michael Rubenstein, Chief Growth and Innovation Officer at Alcan Packaging, talks about applying a philosophy of sustainability to the pharmaceutical packaging supply chain. 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/631118null HTML http://pharmtech.findpharma.com/pharmtech/IT/Simplifying-data-management/ArticleStandard/Article/detail/637637?contextCategoryId=40939&ref=25 Paper is no longer a sufficient format for information storage and interchange in the pharmaceutical industry; documents are inflexible and costly for production and storage. 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637637null XML http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Plastic-Prefilled-Syringes-A-Better-Fit-for-Autoin/ArticleStandard/Article/detail/638757?contextCategoryId=40939&ref=25 The authors describe the ways in which plastic prefilled syringes can be an alternative that provides consistent performance, protects drugs prone to degradation, and enhances patient safety. 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638757/pt-1109-sup-fig-1-p7B_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638757null XML http://pharmtech.findpharma.com/pharmtech/Outsourcing/Reality-not-insanity/ArticleStandard/Article/detail/637636?contextCategoryId=40939&ref=25 Apopular definition of insanity is repeating the same task over and over again while expecting a different result. It would appear, therefore, that many people in the contract services industry think the major global bio/pharma companies are insane. 2009-11-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637636null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Cargill-updates-industry-on-portfolio-innovations/ArticleStandard/Article/detail/637079?contextCategoryId=40939&ref=25 Cargill has recently announced a number of innovations connected to its range of polyol excipients. 2009-10-30T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637079null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Tracks-Influenza-A-Treatment-with-Prescription/ArticleStandard/Article/detail/637177?contextCategoryId=40939&ref=25 The US Food and Drug Administration is using prescription data from Wolters Kluwer Pharma Solutions to track the treatment of influenza A (H1N1) and other influenza viruses, according to a statement that the company released last week. 2009-10-29T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637177null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?contextCategoryId=40939&ref=25 Also, Astellas and Medivation sign development pact; WuXi PharmaTech appoints VP of business development, more... 2009-10-29T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637174null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Issues-New-Guidance-on-Drug-Labeling-and-Pharm/ArticleStandard/Article/detail/635534?contextCategoryId=40939&ref=25 The US Food and Drug Administration issued a guidance for industry and review staff titled, Labeling for Human Prescription Drug and Biological Products-Determining Established Pharmacologic Class for Use in the Highlights of Prescribing Information. 2009-10-22T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635534null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Pfizer-and-Wyeth-Begin-Operations-as-a-Combined-Co/ArticleStandard/Article/detail/635536?contextCategoryId=40939&ref=25 Following the completion of its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York) began joint operations of the combined company last week. 2009-10-22T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635536null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-19-2009-Lonza-Drops-Bid-for-Patheon-Pe/ArticleStandard/Article/detail/635533?contextCategoryId=40939&ref=25 Company and People Notes: SurModics forms agreement with Roche and Genentech; Hospira names Daphne Jones senior VP and chief information officer; more... 2009-10-22T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635533null HTML http://pharmtech.findpharma.com/pharmtech/Article/October-2009-Editors-Picks-Products-from-Emerson-a/ArticleStandard/Article/detail/634670?contextCategoryId=40939&ref=25 PharmTech's monthly newsletter, Equipment & Processing Report, reviews the Editor's Picks for the October 2009 edition from Emerson and Minitab. 2009-10-21T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/634670null HTML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Reducing-Supercooling-during-the-Lyophilization-of/ArticleStandard/Article/detail/634666?contextCategoryId=40939&ref=25 The manufacturing process, which influences a drug's safety and efficacy, is particularly critical for drugs administered through injection, and personnel must closely supervise lyophilization to ensure product quality. 2009-10-21T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/634666null HTML http://pharmtech.findpharma.com/pharmtech/In+the+Mixer/New-Pharmaceutical-Pump-Designs-Can-Provide-a-Comp/ArticleStandard/Article/detail/634669?contextCategoryId=40939&ref=25 Economic pressures are forcing pharmaceutical manufacturers to look for ways to become more competitive. Many companies realize that they must reduce operating costs but maintain or improve product quality. 2009-10-21T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/634669null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/IMS-Raises-Global-Pharma-Market-Growth-Forecast/ArticleStandard/Article/detail/633983?contextCategoryId=40939&ref=25 IMS Health delivered some good news last week with its updated pharmaceutical market forecast. 2009-10-15T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/633983null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Cancer-Drugs-Account-for-5-of-Overall-Drug-Spendin/ArticleStandard/Article/detail/633985?contextCategoryId=40939&ref=25 For the first time, cancer treatments accounted for 5% of overall drug spending in the first half of 2009, said Medco Health Solutions in a press release last week. 2009-10-15T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/633985null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-12-2009-GSK-and-Prosensa-Form-Pact-Car/ArticleStandard/Article/detail/633981?contextCategoryId=40939&ref=25 Company and People Notes: Bayer Schering Pharma forms collaboration with Compugen; Takeda San Francisco appoints VP of process science; more... 2009-10-15T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/633981null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-5-2009-Merck-and-CSL-Sign-Flu-Vaccine-/ArticleStandard/Article/detail/632124?contextCategoryId=40939&ref=25 Company and People Notes: GSK forms joint venture with China-based Jiangsu Walvax Biotech; Sigma-Aldrich appoints VP and board member; more... 2009-10-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632124null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/USP-Issues-New-Quality-Standards-for-Heparin/ArticleStandard/Article/detail/632148?contextCategoryId=40939&ref=25 The US Food and Drug Administration issued an alert to healthcare professionals of a change in heparin manufacturing that is expected to decrease the drug's potency. 2009-10-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632148null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Companies-Update-Pandemic-H1N1-Flu-Vaccine-Project/ArticleStandard/Article/detail/632147?contextCategoryId=40939&ref=25 GlaxoSmithKline (London), Novartis (Basel, Switzerland), sanofi Aventis (Paris), and Baxter International (Deerfield, IL) recently provided updates as to the development, manufacture, or shipment of pandemic (H1NI) vaccines. 2009-10-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632147null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Releases-Draft-Guidance-for-REMS/ArticleStandard/Article/detail/632127?contextCategoryId=40939&ref=25 The US Food and Drug Administration published its first draft guidance for industry about Risk Evaluation and Mitigation Strategies (REMS) on Sept. 30, 2009. 2009-10-08T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632127null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Pediatric-Exclusivity-and-Drug-Development-Require/ArticleStandard/Article/detail/631379?contextCategoryId=40939&ref=25 Although children suffer from many of the same diseases as adults and are often treated with the same drugs, only a small fraction of the drugs marketed and used as therapies in the United States have been studied in pediatric patients 0–16 years of age. Recent data demonstrates that only about 25% of approved drugs marketed in the United States have adequate pediatric data to support approval of product labeling by FDA for dosing, safety, or efficacy in children. This lack of appropriate pediatric testing and labeling increases the chances of incorrect dosing, thereby exposing pediatric patients to either an increased risk of adverse reactions or less than optimal therapeutic benefits. 2009-10-05T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631379null REMOTE http://pharmtech.findpharma.com/pharmtech/Manufacturing/The-Regulatory-Paradox-of-Laboratory-Developed-Tes/ArticleStandard/Article/detail/631381?contextCategoryId=40939&ref=25 The development of increasingly more complex and sophisticated in vitro diagnostic (IVD) devices by clinical laboratories has precipitated FDA concern regarding a lack of product controls. These tests are often produced using available marketed kits, may include components purchased from a commercial supplier, and are offered for use as a diagnostic service. FDA contends that test ingredients or components used in the production of LDTs are essentially unregulated, therefore, of unpredictable quality. The regulatory boundary between FDA-regulated medical devices LDTs exempt from FDA jurisdiction remains somewhat blurred; however, the looming finalization of the CPG and IDVMIA guidance documents stand to better clarify this borderline. 2009-10-05T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631381null REMOTE http://pharmtech.findpharma.com/pharmtech/Whitepapers/Risk-Evaluation-and-Mitigation-Strategies-REMS-Und/ArticleStandard/Article/detail/614075?contextCategoryId=40939&ref=25 On March 25, 2008, new legislation designated as the Food and Drug Administration Amendments Act of 2007 (FDAAA; "the Act") took effect, which directed FDA to develop a systematic, scientifically sound approach to managing the risk-benefit ratio of a drug throughout its lifecycle, with an explicit focus on postapproval safety. In September 2009, FDA announced a draft guidance to assist sponsors in the preparation of a REMS. The guidance provides links to a number of resources available at FDA to aid in REMS preparation. 2009-10-05T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/614075null REMOTE http://pharmtech.findpharma.com/pharmtech/News/500-jobs-created-by-Almac-expansion/ArticleStandard/Article/detail/630113?contextCategoryId=40939&ref=25 Almac's expansion plans in Northern Ireland (UK) could see the creation of more than 500 jobs during the next 5 years. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630113null HTML http://pharmtech.findpharma.com/pharmtech/Article/How-to-Develop-a-Practical-and-Compliant-Vendor-Qu/ArticleStandard/Article/detail/632990?contextCategoryId=40939&ref=25 This article introduces the "Q.U.E.S.T." approach for vendor qualification, a practical and compliant methodology for pharmaceutical and biopharmaceutical companies to qualify vendors and hence make well-informed purchasing-related decisions. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632990/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632990null XML http://pharmtech.findpharma.com/pharmtech/Special+Section%3A+Quality+by+Design/Question-Based-Review-An-FDA-Reviewers-Perspective/ArticleStandard/Article/detail/632992?contextCategoryId=40939&ref=25 The author analyzes, from an agency perspective, whether question-based review has improved product quality or made the review process easier for regulators or for industry. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632992/QBD_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632992/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632992null XML http://pharmtech.findpharma.com/pharmtech/IT/PhRMAs-Stake-in-Reform/ArticleStandard/Article/detail/631752?contextCategoryId=40939&ref=25 The nation's healtcare system needs an overhaul, but it has to be done right. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631752null XML http://pharmtech.findpharma.com/pharmtech/Article/Report-From-India/ArticleStandard/Article/detail/631715?contextCategoryId=40939&ref=25 Pharmaceutical companies in India have had a hold on the biotechnology sector for many years, and they're not about to let the follow-on biologics market pass them by. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631715/INDIA_OCT_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631715null XML http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/631714?contextCategoryId=40939&ref=25 Editors' Picks of Pharmaceutical Science & Technology Innovations 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631714null XML http://pharmtech.findpharma.com/pharmtech/Article/Getting-the-Truth-out-of-Dissolution-Testing/ArticleStandard/Article/detail/631721?contextCategoryId=40939&ref=25 Industry, equipment vendors, and regulators are busy refining the precision and reliability of dissolution testing. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631721/Coverstory_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631721null XML http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Packaging-Goes-Green/ArticleStandard/Article/detail/632987?contextCategoryId=40939&ref=25 Pharmaceutical companies get ideas for sustainable packaging from other industries. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632987/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632987null XML http://pharmtech.findpharma.com/pharmtech/Article/New-Leadership-Seeks-to-Transform-FDA/ArticleStandard/Article/detail/631717?contextCategoryId=40939&ref=25 Strict enforcement, new rules, and organizational changes signal an activist tone. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631717null XML http://pharmtech.findpharma.com/pharmtech/Article/Progress-Made-on-the-Path-to-Biosimilars/ArticleStandard/Article/detail/631720?contextCategoryId=40939&ref=25 BIO supports recent Congressional action toward a 12-year data exclusivity period for innovators. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631720null XML http://pharmtech.findpharma.com/pharmtech/Special+Section%3A+Quality+by+Design/Academia-Tackles-QbD-Science-NIPTE-Carries-out-FDA/ArticleStandard/Article/detail/632993?contextCategoryId=40939&ref=25 A review of NIPTE's core projects and its plans for training-and retraining-the pharmaceutical industry. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632993/QBD_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632993/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632993null XML http://pharmtech.findpharma.com/pharmtech/Article/Pharma-Capsules/ArticleStandard/Article/detail/631712?contextCategoryId=40939&ref=25 Brief pharmaceutical news items for October 2009. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631712null XML http://pharmtech.findpharma.com/pharmtech/Article/Standard-Setting-Bodies-Engage-Russia/ArticleStandard/Article/detail/632991?contextCategoryId=40939&ref=25 As the pharmaceutical industry moves further into Central and Eastern Europe and the Commonwealth of Independent States, several standard-setting and regulatory bodies are also increasing collaboration in the region, particularly in Russia. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632991/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632991null XML http://pharmtech.findpharma.com/pharmtech/Article/The-Emerging-Markets-of-the-East/ArticleStandard/Article/detail/631710?contextCategoryId=40939&ref=25 The countries of Central and Eastern Europe and the Commonwealth of Independent States are closing in on global pharmaceutical competition. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631710/russia_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631710null XML http://pharmtech.findpharma.com/pharmtech/Article/CROs-and-CMOs-Go-Further-East/ArticleStandard/Article/detail/632989?contextCategoryId=40939&ref=25 Contract research organizations such as Covance are heading further east through Europe. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632989/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632989null XML http://pharmtech.findpharma.com/pharmtech/Special+Section%3A+Quality+by+Design/Building-a-Framework-for-Quality-by-Design/ArticleStandard/Article/detail/632988?contextCategoryId=40939&ref=25 The author describes the framework needed to implement QbD and achieve the deeper process understanding that is fundamental to QbD. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632988/QBD_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632988/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632988null XML http://pharmtech.findpharma.com/pharmtech/Article/Multinational-Firms-Stake-Claims/ArticleStandard/Article/detail/632994?contextCategoryId=40939&ref=25 This article is part of a Special Report on the Emerging Markets of The East, October 2009 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632994/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632994null XML http://pharmtech.findpharma.com/pharmtech/Article/Global-Regulatory-Submissions-for-QbD-Wyeths-Exper/ArticleStandard/Article/detail/631718?contextCategoryId=40939&ref=25 Representatives of one pilot program participant, Wyeth, outline the experiences and lessons learned for implementing a science- and risk-based approach to drug-development and manufacturing. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631718/QBD_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631718null XML http://pharmtech.findpharma.com/pharmtech/IT/Looking-Ahead-The-Pharmaceutical-Science-Industry/ArticleStandard/Article/detail/631750?contextCategoryId=40939&ref=25 AAPS President offers hope and solutions for the industry's challenging future. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631750null XML http://pharmtech.findpharma.com/pharmtech/Article/Sneaky-and-Suspicious/ArticleStandard/Article/detail/631749?contextCategoryId=40939&ref=25 Like life, the workplace also can have many surprises. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631749null XML http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Delivering-the-Results-in-Drug-Based-Nanotechnolog/ArticleStandard/Article/detail/631719?contextCategoryId=40939&ref=25 New nanotechnology-based delivery systems offer promise in drug delivery, particularly for anticancer therapeutics. 2009-10-02T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631719/ingred_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631719null XML http://pharmtech.findpharma.com/pharmtech/Manufacturing/EMEA-Recommends-Two-H1N1-Vaccines-for-Authorizatio/ArticleStandard/Article/detail/630295?contextCategoryId=40939&ref=25 On September 25, the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) recommended the authorization of two vaccines for use in Europe against the H1N1 influenza: GlaxoSmithKline's (GSK) Pandemrix and Novartis's Focetria. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630295null HTML http://pharmtech.findpharma.com/pharmtech/Ingredients/Abbott-to-Acquire-Solvay-Pharmaceuticals-for-66-Bi/ArticleStandard/Article/detail/630294?contextCategoryId=40939&ref=25 Abbott Laboratories (Abbott Park, IL) agreed to acquire the pharmaceutical business of the Solvay Group (Brussels, Belgium) for EUR 4.5 billion ($6.6 billion) in cash, according to an Abbott press release. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630294null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Biotech-is-Uneven-in-New-EU-Member-States/ArticleStandard/Article/detail/630297?contextCategoryId=40939&ref=25 A new report evaluating the biotechnology sector in new European Union member states and candidate countries has described biotech developments as "uneven" because of contrasting economic strategies in different countries. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630297null HTML http://pharmtech.findpharma.com/pharmtech/Outsourcing/Is-all-sunny-in-Spanish-pharma/ArticleStandard/Article/detail/629828?contextCategoryId=40939&ref=25 Despite the economic downturn, Spain's pharmaceutical industry continues to grow — particularly when it comes to biotechnology. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629828/Sutton_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629828null XML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Seattle-Genetics-Introduces-Sugar-Engineered-Antib/ArticleStandard/Article/detail/630293?contextCategoryId=40939&ref=25 The biopharmaceutical company Seattle Genetics (Bothell, WA) introduced a sugar-engineered antibody (SEA) technology that is designed to increase the potency of monoclonal antibodies through enhanced effector function. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630293null HTML http://pharmtech.findpharma.com/pharmtech/Spotlight/The-rise-of-in-silico-RampD/ArticleStandard/Article/detail/629830?contextCategoryId=40939&ref=25 Even though the pharmaceutical industry has come to recognize the importance and associated benefits of using computers, evolving computer-based simulation technology has still to make a suitable impression. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629830null XML http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Issues-Proposed-Rule-on-CGMPs-for-Combination-/ArticleStandard/Article/detail/630291?contextCategoryId=40939&ref=25 The US Food and Drug Administration issued a proposed rule to clarify the current good manufacturing practice (CGMP) requirements applicable to combination products in the Sept. 23 Federal Register. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630291null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Microreactor-technology-Is-the-industry-ready-for-/ArticleStandard/Article/detail/629827?contextCategoryId=40939&ref=25 Microreactor technology (MRT) has recently been introduced to the pharmaceutical manufacturing circuit as a promising technology for the continuous processing of commercial quantities of pharmaceuticals. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629827/Pavlou_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629827null XML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Promoting-microreactor-technology-to-the-pharma-in/ArticleStandard/Article/detail/626883?contextCategoryId=40939&ref=25 Sophie Walton, Business Manager at CPI UK explains how Centre for Process Innovation (CPI) UK partners with industry to promote microreactor technology (MRT). 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626883null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-28-2009-JampJ-and-Crucell-Enter-Colla/ArticleStandard/Article/detail/630279?contextCategoryId=40939&ref=25 Company and People Notes: Boehringer Ingelheim will acquire Wyeth's animal health business; Amsterdam Molecular Therapeutics appoints CEO; more... 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630279null HTML http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/A-new-tool-to-battle-counterfeits/ArticleStandard/Article/detail/626045?contextCategoryId=40939&ref=25 Jeff Robertson talks about a unique form of micro-tag technology that can be applied to solid dose pharmaceuticals. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626045/thumbnail_thumbnail.gif http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626045null HTML http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Removing-endotoxin-from-biopharmaceutical-solution/ArticleStandard/Article/detail/629825?contextCategoryId=40939&ref=25 Endotoxin removal from a finished product is a major challenge for biopharmaceutical manufacturers; particularly as all endotoxin removal methods have operational limitations and may result in loss of protein. 2009-10-01T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629825/Pattnaik_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629825null XML http://pharmtech.findpharma.com/pharmtech/News/New-pharma-plastic-centers-opened/ArticleStandard/Article/detail/628519?contextCategoryId=40939&ref=25 The Gerresheimer Group is opening two new centres: an R&D center for medical plastic systems in the US and a new production center for pharmaceutical plastic packaging in Spain. 2009-09-25T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628519null HTML http://pharmtech.findpharma.com/pharmtech/News/Vetter-to-open-new-US-facility/ArticleStandard/Article/detail/628521?contextCategoryId=40939&ref=25 Vetter (Germany) is intending to open a technologically advanced customer services facility at the end of 2009 in Chicago (US). 2009-09-25T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628521null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Vaccines-for-low-income-countries/ArticleStandard/Article/detail/628275?contextCategoryId=40939&ref=25 A joint venture between a charity and a pharma giant has led to the creation of the Hilleman Laboratories, which will use a not-for-profit operating model to develop and deliver vaccines to low-income countries. 2009-09-25T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628275null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/What-pharma-can-learn-from-general-manufacturing-i/ArticleStandard/Article/detail/627851?contextCategoryId=40939&ref=25 While pharma is not synchronized with the boom and bust of the general economy, lessons from the business cycle facing manufacturers can enable the pharmaceutical industry to tackle the problems it faces. 2009-09-25T04:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/627851null HTML